Table 2.
Comparison of oesophageal and gastric cancer staging at presentation in 2014 and 2015
| ≤T2 disease | >T2 disease | |||
| Oesophageal | Gastric | Oesophageal | Gastric | |
| 2014 | 4 | 0 | 15 | 8 |
| 2015 | 8 | 0 | 19 | 10 |
| OR (≤T2 oesophageal cancer): 1.58, 95% CI 0.40 to 6.26, p=0.73 OR (≤T2 gastric cancer): N/A, p=1.00 | ||||
| N0/M0 | >N0/M0 | |||
| Oesophageal | Gastric | Oesophageal | Gastric | |
| 2014 | 4 | 1 | 14 | 7 |
| 2015 | 10 | 1 | 17 | 9 |
| OR (localised oesophageal cancer): 2.06, 95% CI 0.53 to 8.01, p=0.34 OR (localised gastric cancer): 0.78, 95% CI 0.04 to 14.75, p=1.00 | ||||
N/A, not applicable.